Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)

Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)

Bibliographic Details
Main Author: Andreas Bohle
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia 2011-04-01
Series:International Brazilian Journal of Urology
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000200024
id doaj-cbbfdfebd96144db81e0f2c774b0538d
record_format Article
spelling doaj-cbbfdfebd96144db81e0f2c774b0538d2020-11-24T22:40:34ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-55381677-61192011-04-0137228128210.1590/S1677-55382011000200024Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)Andreas Bohlehttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000200024
collection DOAJ
language English
format Article
sources DOAJ
author Andreas Bohle
spellingShingle Andreas Bohle
Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
International Brazilian Journal of Urology
author_facet Andreas Bohle
author_sort Andreas Bohle
title Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
title_short Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
title_full Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
title_fullStr Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
title_full_unstemmed Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)
title_sort sequential intravesical chemoimmunotherapy with mitomycin c and bacillus calmette-guérin and with bacillus calmette-guérin alone in patients with carcinoma in situ of the urinary bladder: results of an eortc genito-urinary group randomized phase 2 trial (30993)
publisher Sociedade Brasileira de Urologia
series International Brazilian Journal of Urology
issn 1677-5538
1677-6119
publishDate 2011-04-01
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382011000200024
work_keys_str_mv AT andreasbohle sequentialintravesicalchemoimmunotherapywithmitomycincandbacilluscalmetteguerinandwithbacilluscalmetteguerinaloneinpatientswithcarcinomainsituoftheurinarybladderresultsofaneortcgenitourinarygrouprandomizedphase2trial30993
_version_ 1725704469395537920

Similar Items